Literature DB >> 1743325

Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation.

J Balaśch1, V Arroyo, F Carmona, J Llach, W Jiménez, J C Paré, J A Vanrell.   

Abstract

OBJECTIVE: To investigate the pathogenesis of the systemic hemodynamic disturbance and the renal production of vasodilator prostaglandins (PGs) in the ovarian hyperstimulation syndrome.
DESIGN: Prospective longitudinal study.
SETTING: Assisted Reproduction Unit of the Hospital Clínic i Provincial in Barcelona. PATIENTS: Five in vitro fertilization patients with ascites because of severe ovarian hyperstimulation syndrome. MAIN OUTCOME MEASURES: Measurement during the syndrome and 4 weeks after recovery of the following: cardiac output, arterial pressure, estimated peripheral vascular resistances, hematocrit, standard renal function tests, plasma renin activity, plasma aldosterone, norepinephrine and antidiuretic hormone concentrations, and urinary excretion of PGE2 and 6-keto-PGF1 alpha.
RESULTS: During the syndrome, all patients showed arterial hypotension (74.2 +/- 3.8 versus 85.8 +/- 1.0 mm Hg), tachycardia, increased cardiac output (6.4 +/- 0.2 versus 4.4 +/- 0.1 L/min), low peripheral vascular resistance (929 +/- 52 versus 1,568 +/- 51 dyn/sec per cm-5), high plasma levels of renin (72 +/- 25 versus 0.5 +/- 0.1 ng/mL per h-1), norepinephrine (639 +/- 141 versus 203 +/- 21 pg/mL) and antidiuretic hormone (6.1 +/- 1.6 versus 1.5 +/- 0.1 pg/mL), and increased urinary excretion of PGE2 (551 +/- 152 versus 106 +/- 44 pg/min) and 6-keto-PGF1 alpha (470 +/- 76 versus 99 +/- 11 pg/min). No evidence of hemoconcentration, as assessed by hematocrit, was observed in any patient.
CONCLUSIONS: (1) Severe ovarian hyperstimulation syndrome is related to marked arteriolar vasodilation that leads to underfilling of the arterial vascular compartment and stimulation of endogenous vasoconstrictor systems and (2) the increased urinary excretion of PGs probably represents a homeostatic response to antagonize the renal effects of these systems.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743325     DOI: 10.1016/s0015-0282(16)54720-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Cytokine levels in a patient with severe ovarian hyperstimulation syndrome before and after the ultrafiltration and reinfusion of ascitic fluid.

Authors:  M Ito; T Harada; T Iwabe; M Tanikawa; N Terakawa
Journal:  J Assist Reprod Genet       Date:  2000-02       Impact factor: 3.412

2.  Ovarian stimulation and liver dysfunction: Is a clinical relationship possible? A case of hepatic failure after repeated cycles of ovarian stimulation.

Authors:  Emilio Giugliano; Elisa Cagnazzo; Giancarlo Pansini; Fortunato Vesce; Roberto Marci
Journal:  Clin Exp Reprod Med       Date:  2013-03-31

Review 3.  Autonomic circulatory control during pregnancy in humans.

Authors:  Qi Fu; Benjamin D Levine
Journal:  Semin Reprod Med       Date:  2009-06-15       Impact factor: 1.303

4.  Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis.

Authors:  D Grochowski; E Sola; M Kulikowski; W Kuczyński; S Wołczyński; M Szamatowicz
Journal:  J Assist Reprod Genet       Date:  1995-07       Impact factor: 3.412

5.  Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction.

Authors:  Ataollah Ghahiri; Neda Mogharehabed; Minoo Movahedi; Naeimehossadat Hosseini
Journal:  J Res Med Sci       Date:  2015-07       Impact factor: 1.852

Review 6.  Hormones and hemodynamics in pregnancy.

Authors:  Oleksandra Tkachenko; Dmitry Shchekochikhin; Robert W Schrier
Journal:  Int J Endocrinol Metab       Date:  2014-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.